Table of Contents
TOPIC HIGHLIGHT
| Venous and Arterial Thrombosis is there a Link? | PDF HTML |
| Paolo Prandoni, Marta Milan, Valentina Vedovetto, Lucia Sarolo, Franca Bilora | 29-34 |
| Fragile patients with venous thromboembolism. What did we learn from RIETE. | PDF HTML |
| Eugenio BUCHERINI, Luis Manuel HERNÁNDEZ-BLASCO, Carmen FERNÁNDEZ-CAPITÁN, Alicia LORENZO, Aurora VILLALOBOS, Raimundo TIRADO, Isabelle MAHÉ, Jana HIRMEROVA, Paolo Prandoni, Manuel MONREAL | 35-39 |
EDITORIAL
REVIEW
| Role of erythropoietin and its receptor beyond erythropoiesis | PDF HTML |
| Katarzyna Aleksandra Lisowska | 42-51 |
| The Role of Macrophage in the Pathogenesis of Brain Arteriovenous Malformation | PDF HTML |
| Li Ma, Yi Guo, Yuan-Li Zhao, Hua Su | 52-56 |
| Use of Natural Killer Cells for Acute Leukemia Patients | PDF HTML |
| Giovanni Fernando Torelli | 57-60 |
ORIGINAL ARTICLE
| Treatment with yttrium-90 (90Y)-ibritumomab tiuxetan (Zevalin®) in diffuse large B-cell lymphoma: a meta-analysis | PDF HTML |
| Sophie Auger | 61-69 |
| Predictive and prognostic significance of vascular endothelial growth factor (VEGF) and response to VAD protocol of chemotherapy in multiple myeloma patients | PDF HTML |
| ASHRAF M. ELHEFNI | 70-73 |
